• Tetrahydroisoquinolines as P-gp MDR Reversal Agents

  2026-10-03

  Lai and colleagues reported 21 6,7-dimethoxy-tetrahydroisoquinoline derivatives designed to inhibit P-glycoprotein and resensitize Eca109/VCR multidrug-resistant esophageal carcinoma cells. Compound 21 showed the strongest reported activity, with a reversal fold of 654 and supporting evidence from colony formation, flow cytometry, fluorescent substrate accumulation, chemosensitization, and molecular docking.

• Nystatin (Fungicidin) Workflows for Candida Assays

  2026-10-01

  Build reproducible Candida, adhesion, biofilm, and formulation assays with Nystatin (Fungicidin), while controlling DMSO exposure and precipitation. A reference-study-inspired ergosterol workflow also helps researchers test polyene potentiation without overstating clinical or animal-model evidence.

• Dimetridazole BA1077 for Reproducible Assays

  2026-10-01

  Learn how Dimetridazole (SKU BA1077) can be integrated into bacterial culture assays, quorum-sensing studies, infection models, and cell-based viability workflows without confusing antimicrobial activity with host-cell toxicity. The article provides practical controls, formulation guidance, interpretation strategies, and evidence-linked handling recommendations.

• Recombinant Human FGF-19: Practical Assay Guide

  2026-10-01

  Recombinant Human FGF-19 provides a defined, tag-free protein input for FGFR4 binding, cell-response, and metabolic regulation research. It is suitable for controlled in vitro workflows and exploratory model development, but product-level validation should not be interpreted as evidence of therapeutic efficacy or universal activity in every cell type.

• Schisandrin B Protects Lung Epithelium from NiNP Injury

  2026-09-30

  This study identifies a Sirt3-associated mitochondrial redox and lipid-metabolism axis that contributes to nickel nanoparticle-induced lung epithelial injury. By combining systems-level analysis, molecular modeling, and gain- and loss-of-function experiments, it shows that Schisandrin B is associated with increased Sirt3 expression, improved mitochondrial and lipid-related readouts, and reduced apoptosis.

• L. gasseri, NR1I3, and E-Cadherin in Colitis

  2026-09-29

  Qian et al. show that Lactobacillus gasseri ATCC33323 protects against DSS-induced colitis by preserving the intestinal epithelial barrier and increasing E-cadherin through an NR1I3-associated regulatory mechanism. The study combines probiotic treatment, intestinal E-cadherin reduction, barrier measurements, microbiota analysis, and in vitro transcriptional experiments to move beyond a descriptive probiotic effect toward a mechanistic model.

• O-propargyl-puromycin for Protein Synthesis Assays

  2026-09-29

  O-propargyl-puromycin (OPP) converts a short translation pulse into a measurable signal for flow cytometry, imaging, immunoblotting, or proteomics. Its strongest use-case is mechanistic biology: pairing nascent polypeptide labeling with mitochondrial, viability, or cell-state measurements to distinguish altered translation from changes in cell number.

• Direct Mouse Genotyping Kit: Practical PCR Guide

  2026-09-28

  The Direct Mouse Genotyping Kit supports rapid PCR amplification from mouse tissue by producing a PCR-ready lysate without conventional DNA purification. It is suited to routine mouse genetic screening and high-throughput genotyping, but should not be assumed suitable for applications requiring highly purified or high-molecular-weight DNA, such as long-read sequencing.

• AZD1390 Workflows for ATM Inhibition Research

  2026-09-28

  Build a practical AZD1390 workflow for testing ATM-dependent DNA damage responses and radiation sensitivity in glioma and lung cancer models. The guide also shows how to connect G-quadruplex replication stress to ATM signaling without treating a mechanistic hypothesis as an established drug effect.

• HyperPFU™ high-fidelity DNA polymerase: PCR Guide

  2026-09-27

  HyperPFU™ is a proofreading DNA polymerase for amplifying long, GC-rich, or otherwise difficult DNA templates when sequence accuracy and blunt-ended products matter. It is suitable for cloning and sequencing workflows, but not for protocols that require 3′-A overhangs or sticky-ended PCR products.

• Z-VAD-FMK: Practical Apoptosis Workflows

  2026-09-26

  Use Z-VAD-FMK as a mechanistic control to test whether a treatment’s cell-death effect depends on caspases—not as a stand-alone readout of apoptosis. This workflow connects caspase inhibition to mitochondrial stress studies in acute myeloid leukemia (AML), with practical controls for dose selection, solvent matching, and interpretation.

• Annexin V-FITC/PI Apoptosis Assay Kit Guide

  2026-09-25

  This kit helps researchers distinguish cells with exposed phosphatidylserine from cells with compromised plasma membranes using Annexin V-FITC and PI. It is intended for research apoptosis assays by flow cytometry or fluorescence microscopy, not for diagnosis or for identifying the cause of cell death.

• SNORA38B Reprograms NSCLC Growth and Immunity

  2026-09-25

  Zhuo et al. identify SNORA38B as an oncogenic small nucleolar RNA associated with poor prognosis in non-small cell lung cancer (NSCLC). Their experiments connect SNORA38B binding to E2F1 with increased GAB2/AKT/mTOR signaling and an immunosuppressive tumor microenvironment; SNORA38B-targeting locked nucleic acids also improved the response to immune checkpoint blockade in a mouse model.

• Perifosine Workflows for Akt and Apoptosis Research

  2026-09-24

  Use Perifosine (KRX-0401) to probe Akt dependence in cancer-cell apoptosis assays, radiation studies, and carefully controlled ischemia/reperfusion experiments. This guide pairs practical dose-finding and troubleshooting with a clear distinction between the compound’s established antitumor applications and its proposed use as a pathway probe in neuroprotection research.

• BMS 309403: Reading Lipid Flux in Atherosclerosis

  2026-09-24

  Discover how BMS 309403 can help distinguish FABP4-dependent lipid handling from upstream signaling and downstream foam-cell phenotypes. This evidence-led guide interprets recent SERCA2 research and highlights assay decisions that strengthen causal conclusions.

8013 records 1/535 page Next 12345 下5页 Last page